Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Compare before deciding. Treatment of relapsing-remitting multiple sclerosis.
The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS.
Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.
The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
New magnetic resonance imaging biomarkers for the diagnosis of multiple sclerosis.
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis.
Sex-specific control of CNS autoimmunity by p38 MAPK signaling in myeloid cells.
JCV-negative natalizumab-associated progressive multifocal leukoencephalopathy: a clinico-radiological diagnosis.
New data identify an increasing sex ratio of multiple sclerosis in Sweden.
Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation.
Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain.
Neuroantigen-Specific Autoregulatory CD8+ T Cells Inhibit Autoimmune Demyelination through Modulation of Dendritic Cell Function.
The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.
Tried-and-True Antibiotic May Block Conversion to MS
Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination.
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Is the use of the trivalent influenza vaccine against A (H1N1) pdm09 associated with an increased risk of post-vaccination acute disseminated encephalomyelitis?
Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes.
New drug for relapsing multiple sclerosis.
Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease.
Ulcerative Colitis and Perfluorooctanoic Acid (PFOA) in a Highly Exposed Population of Community Residents and Workers in the Mid-Ohio Valley.
Integrin-based therapeutics: biological basis, clinical use and new drugs.
Prognostic Factors of MS Conversion in Optic Neuritis.

Pages